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Abstract. 
 
To investigate the role that myosin Va plays 
in axonal transport of organelles, myosin Va–associated 
organelle movements were monitored in living neurons 
using microinjected ﬂuorescently labeled antibodies to 
myosin Va or expression of a green ﬂuorescent protein–
myosin Va tail construct. Myosin Va–associated or-
ganelles made rapid bi-directional movements in both 
normal and 
 
dilute-lethal
 
 (myosin Va null) neurites. In 
normal neurons, depolymerization of microtubules by 
nocodazole slowed, but did not stop movement. In con-
trast, depolymerization of microtubules in 
 
dilute-lethal
 
 
neurons stopped movement. Myosin Va or synaptic ves-
icle protein 2 (SV2), which partially colocalizes with 
myosin Va on organelles, did not accumulate in 
 
dilute-
lethal
 
 neuronal cell bodies because of an anterograde 
bias associated with organelle transport. However, SV2 
showed peripheral accumulations in axon regions of 
 
di-
lute-lethal
 
 neurons rich in tyrosinated tubulin. This sug-
gests that myosin Va–associated organelles become 
stranded in regions rich in dynamic microtubule end-
ings. Consistent with these observations, presynaptic 
terminals of cerebellar granule cells in 
 
dilute-lethal
 
 mice 
showed increased cross-sectional area, and had greater 
numbers of both synaptic and larger SV2 positive vesi-
cles. Together, these results indicate that myosin Va 
binds to organelles that are transported in axons along 
microtubules. This is consistent with both actin- and mi-
crotubule-based motors being present on these or-
ganelles. Although myosin V activity is not necessary 
for long-range transport in axons, myosin Va activity is 
necessary for local movement or processing of or-
ganelles in regions, such as presynaptic terminals that 
lack microtubules.
Key words: myosin Va • actin • microtubules • or-
ganelles • 
 
dilute-lethal
 
T
 
HE
 
 transport requirements of neurons are particu-
larly demanding because of their highly polarized
and complex shapes. Transport of organelles to
their proper locations in neurons may require the coopera-
tive interaction between microtubule- and actin-based mo-
tors (Langford, 1995). Fast axonal transport of organelles
requires microtubule-based motor activity (reviewed in
Hirokawa, 1993). However, if neurons are grown without
microtubules, organelles are still transported at reduced
rates within the shorter axon-like processes that form
(Morris and Hollenbeck, 1995). Actin-based motors (myo-
sins) may be responsible for this residual component of
transport in the absence of microtubules. Myosin Va is a
likely candidate (Evans et al., 1997, 1998; Tabb et al.,
1998).
Myosin Va is the product of the 
 
dilute
 
 locus in mice
(Mercer et al., 1991; Cheney et al., 1993). 
 
Dilute
 
 mutations
affect both skin and hair color and, in severe alleles, pro-
duce neurological symptoms that lead to death (Mercer et al.,
1991). Myosin Va is an unconventional myosin that has
biochemical properties compatible with a transport func-
tion in vivo (Espreafico et al., 1992; Cheney et al., 1993;
Wolenski et al., 1995). Recent data indicate that the myo-
sin Va heavy chain can interact directly with a microtu-
bule-based transport motor, the kinesin heavy chain
(Huang et al., 1999). Organelles destined for transport to
the cell periphery may therefore contain both microtubule
and actin-based motors, possibly arranged as a single mo-
tor complex.
Myosin Va associates with vesicles in cultured neurons
(Evans et al., 1997). A population of vesicles enriched in
myosin Va has been purified from brain (Evans et al.,
1998). A substantial fraction of these (
 
z
 
90 nm) vesicles
have myosin Va tightly bound to the surface and are cola-
beled with markers for synaptic vesicles. When activated,
the vesicles can drive the movement of actin filaments in
vitro. A function-blocking antibody to myosin Va stopped
the movement. Synaptic vesicle proteins also associate
with myosin Va in a calcium-dependent manner (Prekaris
and Terrian, 1996). Myosin V is bound to squid axoplasm-
derived organelles that move on both microtubules and
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actin filaments (Kuznetsov et al., 1992; Tabb et al., 1998).
There, antibodies to squid myosin V inhibited organelle
movements on actin. Furthermore, 
 
dilute-lethal
 
 mice show
abnormal distributions of smooth endoplasmic reticulum
in Purkinje cell neurons (Takagishi et al., 1996). While or-
ganelles move on actin filaments in intact growth cones
(Evans and Bridgman, 1995), the motor responsible for
this movement is unknown. We hypothesize that myosin
Va contributes to movement of vesicles in intact neurons.
We test that hypothesis here.
Myosin Va may play an essential role in long-range me-
lanosome movement and localization. Myosin Va binds to
melanosomes (Provance et al., 1996; Nascimento et al.,
1997; Wu et al., 1997) and has also been implicated in 
 
Xe-
nopus
 
 melanophore movement (Rogers and Gelfand,
1998). In the absence of myosin Va, melanosomes concen-
trate abnormally in the perinuclear region of melanocytes,
suggesting a role in melanosome transport (Provance et al.,
1996; Wei et al., 1997; Wu et al., 1997). Recently, however,
the importance of myosin Va motor activity for melano-
some long-range transport has been challenged by results
that favor a capture model for melanosome localization in
melanocytes (Wu et al., 1998). In this model, melanosome
localization is determined by bi-directional microtubule-
dependent melanosome movements coupled with actomy-
osin Va–dependent capture of melanosomes in the periph-
ery of the cell. The minimum requirement for the capture
mechanism is the tethering of melanosomes to actin fila-
ments. Although a capture mechanism does not require
actin-based transport, melanosome movement appears to
be at least partially dependent on myosin Va activity (Wu
et al., 1998). This suggests that short-range melanosome
movements in peripheral regions of dendrites may be my-
osin Va dependent. It is unknown if myosin Va may act as
a tether or mediate primarily short-range movements
within defined regions of neurons. Therefore, we also
tested this hypothesis.
These two hypotheses were tested with a set of experi-
ments on neurons cultured from 
 
dilute-lethal
 
 mice, which
do not express myosin Va. The goals were to: (a) test the
requirement of myosin Va motor activity for movement of
myosin Va–associated organelles in axons, (b) determine
if myosin Va–associated organelles can move under condi-
tions where microtubules have been eliminated, and (c)
determine if the capture paradigm proposed for myosin
Va–mediated melanosome localization can explain the
localization and dynamics of myosin Va–associated or-
ganelles in neurons.
Myosin Va motor activity was found to be unnecessary
for organelle movement in axons. Instead, microtubules
were found to be required for the rapid, bi-directional my-
osin Va–associated organelle movements that were ob-
served in both normal and 
 
dilute-lethal
 
 axons. Thus, myo-
sin Va appears to be mostly a passive passenger on
organelles during normal microtubule-mediated long-
range axonal transport.
Unexpectedly, myosin Va–associated organelles did not
concentrate in cell bodies of neurons of 
 
dilute-lethal
 
 mice.
Instead, myosin Va–associated organelles accumulated pe-
ripherally in axon areas rich in microtubule ends, due in
part because of a bias toward anterograde transport. Thus,
the apparent incompatibility with the capture model pre-
 
sented for melanocytes may be due more to differences in
the net balance of anterograde and retrograde transport
than to an incompatibility with a myosin Va–dependent
tethering. These results support the hypothesis that coop-
eration between the two filament systems (microtubules
and actin filaments) is necessary for localization and traf-
ficking of organelles in vertebrate axons and their termi-
nations. Myosin Va–mediated transport appears to be nec-
essary for proper short-range transport or processing of
organelles in microtubule-deficient regions such as nerve
terminals. This may include a role in local transport to ves-
icle fusion sites or “loading” myosin Va–associated or-
ganelles destined for retrograde transport onto microtu-
bule tracks in peripheral regions of the neuron. It also
suggests that in different regions of neurons either micro-
tubules or actin filaments may predominate as the essen-
tial transport tracks.
 
Materials and Methods
 
Cell Culture
 
Explant and dissociated cultures of superior cervical ganglion (SCG)
 
1
 
neurons were prepared from embryonic rats (E19) or postnatal mice (P0)
as described previously (Dailey and Bridgman, 1993; Evans et al., 1997).
For microinjection and gene gun experiments, cells were plated on sub-
strates coated with 0.1–0.2 mg/ml polyornithine followed by laminin (16
 
m
 
g/ml). Microinjection was performed 1–3 d after plating. For cultures
grown in nocodazole or latrunculin, the drug was added from stock solu-
tions prepared in DMSO directly to the plating medium (unless indi-
cated), and then exchanged for fresh medium 
 
1
 
 drug every 48 h. The final
DMSO concentration did not exceed 0.01%. Latrunculin A was used at a
concentration of 0.1 
 
m
 
g/ml (Spector et al., 1989). Cytochalasin E was used
at a concentration of 20 
 
m
 
g/ml (Morris and Hollenbeck, 1995). Nocoda-
zole was used at a concentration of 3.3 
 
m
 
g/ml unless indicated.
SCG neurons from 
 
dilute-lethal
 
 mice were more sensitive to nocoda-
zole than cells from rats or heterozygous mice. Less than 10% of the cells
plated directly in medium containing nocodazole-developed processes af-
ter 3 d in culture (compared with 
 
z
 
70% in controls). Therefore, a modi-
fied approach was used. SCG neurons from 
 
dilute-lethal
 
 and heterozygous
littermates were plated in normal medium and grown for either 4 or 16 h.
The cultures were then switched to medium containing nocodazole. Two
different concentrations of nocodazole were used to depolymerize micro-
tubules from neurites. Cultures grown for 4 h received 0.1 
 
m
 
g/ml, while
cultures grown for 16 h received 0.15 
 
m
 
g/ml nocodazole.
 
Immunoblots
 
An affinity-purified antiserum to rat myosin Va was used on immunoblots
of homogenized whole brain to identify 
 
dilute-lethal
 
 (d
 
l-20J
 
/d
 
l-20J
 
) P0 mouse
pups. The methods were the same as previously described (Evans et al.,
1997).
 
Antibody Microinjection
 
The antiserum used for microinjection was made against a maltose bind-
ing protein—rat myosin Va tail fusion protein. The myosin Va peptide
corresponded to amino acids 1005–1830 of the mouse myosin Va se-
quence, which includes part of the rod and the entire globular tail
(Cheney et al., 1993). The affinity purification and specificity of the antise-
rum has been described previously (Evans et al., 1997). An IgG fraction of
the affinity-purified antiserum was used for conjugation with indocarbocy-
anine (Cy3). The conjugation was carried out according to instructions
provided by the manufacturer of the dye (BDS). The conjugate was sepa-
rated from free dye on a G25 column and eluted in injection buffer (100 mM
KCL, 10 mM Na
 
2
 
HPO
 
4
 
, pH 7.2). The concentration of dye compared with
 
1. 
 
Abbreviations used in this paper:
 
 BDS, biological detection systems;
Cy3, indocarbocyanine; GFP, green fluorescent protein; iu, intensity units;
SCG, superior cervical ganglion; SV2, synaptic vesicle protein 2. 
Bridgman 
 
Myosin Va Dynamics
 
1047
 
protein was estimated from absorbance at 556 and 280 nm; the ratio was 5:1.
The resulting protein solution was concentrated threefold using a Cen-
triprep-30 concentrator. The activity was tested by immunofluorescence
labeling of cultured SCG neurons. The distribution of label was identical
to that obtained with the nonconjugated purified antiserum. Before mi-
cropipette filling, the solution was centrifuged for 15 min at maximum
speed in a microcentrifuge. An Eppendorf microinjection system
equipped with Femtotips was used for pressure microinjection. Consider-
ing the appearance in phase contrast and ability to retain dye, 
 
z
 
60–80%
of the rat cells survived the injection processes. Mouse neurons were more
difficult to inject and so most microinjection experiments used rat neu-
rons. Healthy cells were imaged 15 min to 5 h after microinjection unless
otherwise indicated.
 
Biolistics
 
A rat myosin Va cDNA clone containing the coil–coil and globular tail,
but lacking the IQ repeats and motor domain (Evans et al., 1997) was in-
serted into a green fluorescent protein (GFP) vector (Clontech) and am-
plified in bacteria. Purified plasmid DNA was used for transfection. 1- or
1.6-
 
m
 
m gold particles were coated with 2 
 
m
 
g DNA per mg gold according
to the manufacturer’s instructions. SCG cultures were transfected with a
hand-held Helios gene gun (Bio-Rad Laboratories) using a pressure of
70–80 psi 1–3 d after plating.
 
Fluorescence Imaging of Live Cells
 
Neurons microinjected with myosin Va-Cy3 antibodies, or expressing the
GFP-myosin Va tail construct, were imaged at 37
 
8
 
C on an inverted micro-
scope (Olympus Corp.) with a 100
 
3
 
 1.4 NA lens (Nikon Inc.), unless oth-
erwise indicated. Before imaging, the cultures were switched to a Hepes-
based culture medium (
 
1
 
 or 
 
2
 
 the appropriate drug). A 100-W mercury
arc lamp was used for illumination. The light was attenuated with a neu-
tral density filter (25% transmittance) and shuttered between exposures.
Images were collected using a cooled, slow scan CCD (C250; Photomet-
rics) containing a 512 
 
3 
 
512 pixel chip (thinned, back illuminated; Tek-
tronix Inc.). The images were binned (2 
 
3 
 
2). Exposures were 0.25 or 0.5 s
at 6- or 5-s intervals.
 
Immunofluorescence
 
Cultures were fixed for 20–30 min with a warm (37
 
8
 
C) solution of 4%
paraformaldehyde (EM grade; EM Sciences) in 0.1 M cacodylate buffer,
pH 7.4, containing 10 mM CaCl
 
2
 
 and 10 mM MgCl
 
2
 
. Cells were permeabi-
lized with 0.1% saponin or 0.1% Triton in the same buffer for 30 min.
They were incubated with blocking solution (8 mg/ml BSA, 5% goat se-
rum, 0.5% fish gelatin) for 20–30 min, and then labeled with primary anti-
bodies diluted in a 1/5 dilution of the blocking solution for 1 h. The anti–
rat myosin Va affinity purified antiserum was used at a concentration of
0.5 
 
m
 
g/ml. The SV2 mAb (gift of Dr. K. Buckley) was used at a 1/200 dilu-
tion. The anti–synaptophysin mAb (Sigma Chemical Co.) was used at a
1/1,000 dilution. Secondary antibody (minimal species cross-reacting anti-
bodies; Jackson Immunochemicals) incubations were for 45–60 min; dilu-
tions ranged from 1/200 (FITC) to 1/1,000 (Cy3). An antifade agent
(Vectashield) was used to minimize photobleaching during imaging.
To determine the degree of colocalization of fluorescent spots, the 16-
bit images were converted to 8 bits and superimposed in two different col-
ors. They were scored as “colocalized” if their fluorescent area over-
lapped and the peak brightness of the SV2 or synaptophysin staining was
at least 20% of the brightness of the myosin Va staining. Although this
may underestimate the degree of association between the two labels, it
prevents the possibility of scoring spots for colocalization that show ap-
parent association due to fluorescence filter bleed-through.
For quantitation of intensity, values were taken directly from flat field–
corrected 16-bit images and were expressed in relative intensity units (iu)
with a maximum possible value of 65,000. For each comparison, the same
exposure time and excitation light intensity were used. Absolute values of
intensity units obtained in different comparisons depended on the inten-
sity of the excitation light and exposure time, which was varied between
experiments.
 
Analysis of Moving Fluorescent Spots
 
The movement of either Cy3-labeled antibody or GFP-myosin Va (tail)
fluorescent spots was analyzed with the following method. Time-lapse im-
ages were adjusted for optimal contrast, and then played in series using
 
the movie tool available in either Isee (Inovision Corp.) or Iplab Spec-
trum (Scanalytics). Sequences from thin neurites with relatively few
clearly visible spots were selected for analysis. This allowed us to follow
the same spot between time points because most spots moved in predict-
able trajectories within a single focal plane. The sequences were zoomed
(2
 
3
 
) and played forward, and then in reverse so that moving spots could
be selected and followed over multiple frames. For each frame, a mark
was placed over the center of an individual spot on a clear acetate overlay
on the computer monitor screen. Spots that could not be followed for at
least four frames (elapsed time of 15 or 18 s) were not used in the final
analysis. This limited the analysis to 
 
z
 
30% of the spots that appeared to
move in a sequence. The distance between marks was measured in milli-
meters, and then converted to micrometers using a calibration slide (Leica
Inc.) imaged with the same optics and CCD detector, and then displayed
on the monitor. The number of time points analyzed for individual spots
was highly variable (4–18). For comparison purposes, the average rate of
displacement was defined as the displacement that occurred between the
first and fifth time point divided by the total elapsed time (20 or 24 s). The
maximum rate was defined as the largest displacement between two time
points divided by the time interval.
 
Electron Microscopy
 
Photoconversion. 
 
Methods were modified from published methods
(Lubke, 1993; Kazca et al., 1997).
 
 
 
Cultures grown on aclar coverslips con-
taining neurons that had been microinjected with the anti–myosin Va-
Cy3–conjugated antibody were returned to the incubator and allowed to
grow for 30–90 min. Cells were fixed with a warm mixture of 0.25% glu-
taraldehyde and 0.32% paraformaldehyde in 0.1 M sodium cacodylate
buffer, pH
 
 5 
 
7.4, containing 10 mM CaCL
 
2 
 
and MgCL
 
2
 
. The cells were re-
identified by fluorescence and phase microscopy and the images recorded.
The cultures were preincubated with cold 1.4 mg/ml DAB (Sigma Fast
DAB; Sigma Chemical Co.) in phosphate buffer for 15 min. After ex-
change with fresh cold solution, the microinjected cells were irradiated us-
ing a 100-W mercury arc lamp on an inverted microscope (Olympus
Corp.). A 25
 
3
 
, 0.75 NA oil immersion lens with high transmittance (Leica
Inc.) was used for the irradiation. Irradiation times were varied from 15 to
35 min. Fluorescence and bright field observations were periodically made
to check for photobleaching and appearance of a dark brown reaction
product. Darkening was detected by 15 min, but photobleaching was not
complete until 
 
z
 
35 min. For controls, cells that were not microinjected,
but on the same coverslip, were irradiated for the same times in fresh
DAB solution. Cells were further fixed with 2.5% glutaraldehyde for 30
min. They were post-fixed with 3% osmium tetroxide for 1 h. Before de-
hydration and embedding, the cells were stained with 1% uranyl acetate
dissolved in 1% sodium acetate for 1 h. The areas containing the photo-
converted cells were cut from the larger aclar coverslip to allow identifica-
tion before thin sectioning. The coverslip piece was flat embedded. Once
the coverslip was removed from the polymerized resin, the cells could be
identified by phase contrast microscopy using the recorded images as
guides, and then further trimmed for sectioning.
 
Immunoelectron microscopy of cultured cells. 
 
After microinjection and
recovery in the incubator, cells were fixed and images were recorded as
described above. Cells were treated with 1 mg/ml sodium borohydride in
PBS for 20 min. The cells were permeabilized with 0.05% filipin in PBS
for 30 min. They were incubated with the antibody blocking solution for
30 min, followed by incubation with 6 nm colloidal gold conjugated to an
anti–rabbit antibody overnight at 4
 
8
 
C.
 
Immunoelectron microscopy of brain slices. 
 
The procedure was modified
from that described by Mrini et al. (1995). Mice were perfused with 0.25%
glutaraldehyde 
 
1
 
 4% paraformaldehyde in cacodylate buffer, pH
 
 
 
7.4 (
 
1 
 
2
mM CaCl
 
2
 
). The brain was removed and immersed in the same fixative for
at least 4 h. The cerebellum was dissected free and embedded in agar for
vibratome sectioning. 50-
 
m
 
m sections were cut. The sections were treated
with freshly made 1 mg/ml sodium borohydride in PBS for 20 min. They
were equilibrated with 35% sucrose 
 
1
 
 14% glycerol in PBS. The sections
were frozen for 15 s in isopentane cooled with liquid nitrogen and thawed
in PBS. This was repeated once. The sections were incubated for 2 h with
PBS containing 0.1% saponin. They were incubated for 2 h in block solu-
tion containing (freshly made) 0.1% saponin. The incubation was changed
to block solution without saponin and continued for another 30 min. They
were incubated overnight at room temperature with the primary antibod-
ies (1/2,000 antimyosin Va; 1/200 anti–SV2 mAb) in a 1/5 dilution of the
block. The incubation was continued at 4
 
8
 
C for another 48 h. After wash-
ing with PBS on rocker for 1 h, the sections were incubated overnight on a 
The Journal of Cell Biology, Volume 146, 1999 1048
 
rocker with gold-conjugated antibodies diluted 1/50 in a 1/5 dilution of the
block. The incubation was continued at 4
 
8
 
C overnight. The sections were
washed on a rocker for 1 h in PBS. They were fixed with 2.5% glutaralde-
hyde in PBS for 1 h. They were postfixed with osmium-potassium ferricya-
nide (Harris and Stevens, 1989) and stained en block with 1% uranyl ace-
tate for 1 h. They were dehydrated and embedded using standard
procedures.
 
Quantitative Analysis of Presynaptic Area and Synaptic 
Vesicle Density
 
EM images were digitized using a high-resolution scanner (Agfa Duo-
scan). The areas of presynaptic terminals were determined by tracing the
perimeter of terminals in Iplab Spectrum. The area in pixels was con-
verted to square micrometers using the calibration bars printed on the EM
negatives. Because the number of mitochondria in terminals were highly
variable and could influence the calculation of synaptic vesicle density,
their area was also determined and subtracted from the measured termi-
nal area for the calculation of synaptic vesicle density. The numbers of
synaptic vesicle profiles were counted and the density calculated from the
corrected terminal area. 
 
Results
 
Localization of Myosin Va-Cy3–labeled Antibodies 
After Microinjection into Cultured Neurons
 
Initially, a series of antibody concentrations and injection
pressures were tested in microinjection experiments. It
was determined that at a minimal injection pressure (
 
,
 
4
psi) and low antibody concentrations (
 
,
 
2 mg/ml) small
bright myosin Va-Cy3 spots appeared in superior cervical
ganglion neurons. The size and distribution of these spots
were consistent with previous results using myosin Va an-
tibody staining on fixed SCG neurons (Evans et al., 1997;
our unpublished results). The bright spots were not appar-
ent immediately after injection, but appeared at the earli-
est time point (15 min) for time-lapse observations after
injection (Fig. 1 A) and persisted at least 16 h (longest
time after injection of observation). Higher concentrations
of antibody (4 mg/ml) or injection pressures produced
much larger bright spots (Fig. 1, B and C). The small
bright spots were highly dynamic, while the large bright
spots never made rapid movements [but in neurites did
make slow (0.28 
 
6 
 
0.08 
 
m
 
m/min,
 
 n 
 
5 
 
15) retrograde move-
ments]. The absence of larger spots from the dimmer mi-
croinjected cells combined with the differences in dynam-
ics suggests that the large spots represented aggregates of
the smaller spots formed by antibody cross-linking.
SCG neurons cultured from 
 
dilute-lethal
 
 mice grow and
extend neurites normally in culture (Evans et al., 1997).
Neurons injected (
 
n
 
 5 
 
8) with the different concentrations
of the antibody showed only a diffuse distribution of fluo-
rescence in cell bodies and neurites (Fig. 1, D and E). The
lack of bright spots in 
 
dilute-lethal
 
 neurons indicates that
the spots are likely to result from specific interactions with
myosin Va–containing structures rather than nonspecific
antibody aggregation or sequestration.
 
Dynamics of Myosin Va-Cy3 Antibody in Neurites
 
The rapid movements of individual small bright spots ob-
served in neurites of rat (21 cells) or heterozygous (d
 
v
 
/d
 
l
 
)
mouse (nine cells) SCG neurons injected with low concen-
trations of antibody at reduced pressures were measured
and analyzed in several different ways. Most frequently,
during a 20-s time period, 
 
z
 
10% of the spots moved and
the remaining were stationary. Movement of spots was bi-
directional; spots sometimes paused or transiently re-
versed direction, but usually made progress either towards
or away from the cell body (Fig. 2, A and B). For analysis,
movements away from the cell body are designated with
positive values, while movements toward the cell body are
indicated by negative values. Among the 40 spots selected
Figure 1. Microinjection of myosin Va-Cy3 affinity purified anti-
serum into normal (A–C) and dilute-lethal (D and E) neurons
produces genotype-specific results. (A) High magnification im-
ages taken at three different focal planes through a rat neuron in-
jected with a low concentration (,2 mg/ml) of the Cy-3–conju-
gated antiserum. One bright spot (arrowhead) is visible, but
smaller, dimmer spots (arrows) predominate. (B) A lower magni-
fication superimposed image of fluorescence on a phase contrast
image of the rat SCG neurons reveals the neurites. (C) Fluores-
cence image from the same cells in B showing the bright spots
(arrowheads) that form upon microinjection of higher concentra-
tions (4 mg/ml) of the antiserum into normal SCG neurons. The
upper neuron has brighter diffuse fluorescence and a greater
number of spots indicating that more antiserum was injected.
Large bright spots may represent aggregates of the small spots in-
duced by antibody cross-linking. Microinjection of antibodies
into neurons from heterozygous mice gave the same result. (D)
An SCG neuron cultured from a dilute-lethal mouse shows only
diffuse fluorescence in the cell body (D) and neurite (E) when
microinjected with the Cy-3–conjugated anti–myosin Va antise-
rum. (E) Two images of a neurite separated by 5 min. Bars: (A)
3 mm; (B and C) 6.5 mm; (D and E) 3 mm. 
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for analysis, there was an apparent overall bias toward an-
terograde movement (69%). To determine whether our
selection process influenced this result, the direction was
scored in three 6-min time-lapse sequences from different
cells for every moving spot (
 
n
 
 5 
 
53). An anterograde bias
(62%) was still detected. An anterograde bias is consistent
with previous reports on axonally transported vesicles in
cultured neurons (Morris and Hollenbeck, 1995; Nakata
et al., 1998). However, chi-square analysis using the as-
sumption that transport was equal in both directions (null
hypothesis) indicated that the apparent bias was not statis-
tically significant (
 
P
 
 . 
 
0.2). The maximum rates of move-
ment achieved by small spots were widely distributed (Fig.
2 C). Because we could not make recordings of spot move-
ment with delays between exposures 
 
,
 
5 s, it is not possible
to be certain of the reason for the variation in maxi-
mum rate. Either the spots achieve highly variable maxi-
mum rates or movements between time-lapse intervals are
 
sometimes interrupted by short pauses at irregular inter-
vals. The time-lapse data is clearly influenced by pauses
and transient direction reversals, since the average rate of
particle movement was considerably less (0.18 
 
6
 
 0.09 
 
m
 
m/s,
 
n 
 
5 
 
24) than the mean maximum rate (0.46 
 
6 
 
0.28 
 
m
 
m/s,
 
n 
 
5 
 
40).
To determine whether the movements of the microin-
jected myosin Va-Cy3–labeled antibodies were character-
istic of a set of structures that are uniquely associated with
myosin Va, some rat SCG neurons were microinjected
with an affinity purified myosin 1
 
a
 
-Cy3 antiserum (Lewis
and Bridgman, 1996). The pattern of fluorescent spots that
formed was identical to that observed in fixed cells stained
with the myosin 1
 
a
 
 antiserum. Fluorescent spots were
both stationary and moving. The movement was bi-direc-
tional. The mean maximum rate of particle movements
from myosin 1
 
a
 
 labeled structures was significantly slower
(0.09 
 
6 
 
0.08 
 
m
 
m/s,
 
 n 
 
5 
 
12; 
 
t
 
 test,
 
 P 
 
, 
 
0.001) than those la-
Figure 2. (A) Time-lapse sequence showing a myosin Va-Cy3 antibody-labeled spot (particle) (arrowhead) making anterograde move-
ments along a rat SCG neurite. Only the small relatively dim spots (visible using a 1003 1.4 NA lens) such as the one shown in this se-
quence, exhibited rapid movements. Large bright spots seen in cell bodies and proximal neurite segments of neurons injected with
larger amounts of antibody never made rapid movements. The interval between images is 6 s. (B) The displacement of individual myo-
sin Va-Cy3 antibody spots (particles) at sequential time points is shown. Positive values indicate movement away from the cell body,
negative values indicate movement towards the cell body. Movement is saltatory; pauses and direction reversal can occur for varying
periods of time. All examples are from rat SCG neurons. (C) The maximum rates of particle movements from untreated neurons
(rat, n 5 27; mouse, n 5 13) show a wide distribution. Bar, 6.4 mm.The Journal of Cell Biology, Volume 146, 1999 1050
beled with antibodies to myosin Va. The slower rate of
movement of the myosin 1a-Cy3 fluorescent spots suggest
that the two different antibodies are reacting specifically
with different populations of transported structures.
Partial Colocalization of Myosin Va-Cy3–labeled Spots 
with a Marker for Synaptic Vesicles
To determine the identity of the myosin Va-Cy3–labeled
spots in microinjected cells, some SCG cultures (six) were
fixed, permeabilized, and labeled with mAb antibodies
to the synaptic vesicle proteins, SV2 and synaptophysin
(Evans et al., 1998). SV2 label showed partial colocaliza-
tion (49%) with the small spots of myosin Va-Cy3 anti-
body (n 5 129) in neurites (Fig. 3 A). This partial colo-
calization was apparent in cell bodies, varicosities, and
enlarged neurite terminations (possible presynaptic termi-
nals), but was difficult to quantitate because of the in-
creased thickness. The partial colocalization may result
from the limited amount of myosin Va-Cy3 antibody mi-
croinjected. Consistent with this possibility, neurons in-
jected with higher concentrations of antibody that showed
large bright spots of antimyosin Va-Cy3 antibody also
showed large bright spots of SV2 label (Fig. 3 B). Superim-
position of images showed that all of the large bright spots
in neurites colocalized and smaller SV2 spots were no
longer detectable. This suggests that the higher concentra-
tion of the myosin Va antibody coaggregated most, if not
all, of the available SV2.
SV2 and synaptophysin have been reported to be ax-
onally transported in different organelle compartments
(Okada et al., 1995; Yonekawa et al., 1998). To determine
whether both of these organelle compartments are trans-
ported in association with myosin Va, a mAb to synapto-
physin was also used for labeling. In contrast to the results
with the SV2 labeling, immunofluorescence labeling of in-
jected neurons with a monoclonal antibody to synapto-
physin produced only very limited colocalization between
the two labels. In neurites, the colocalization was minimal
(#4%). Neurons with large bright spots of myosin Va-Cy3
label occasionally showed corresponding bright spots of
synaptophysin label. However, these spots were usually
smaller than the myosin Va-Cy3 spots. In addition, many
small spots of synaptophysin label still filled the cell body,
indicating that most of the synaptophysin was not coaggre-
gated by the microinjected antibody. In cultures that were
3 d or older, enlarged terminations formed in close opposi-
tion with other neurons (possible synaptic contacts). In
neurons injected with low concentrations of antibody,
bright staining with both synaptophysin and myosin Va-
Cy3 labels was observed within these structures, but it was
difficult to determine the degree of overlap because of
their thickness.
Microinjected Myosin Va-Cy3 Antibodies
Label Organelles
The colocalization of the microinjected myosin Va-Cy3–
and SV2-labeled antibodies provides support for the vesi-
cle association of myosin Va. To test this assumption, two
types of ultrastructural analysis were used. First, the mi-
croinjected myosin Va-Cy3–labeled antiserum was photo-
converted to an electron-dense reaction product, visualized
by thin section EM. This method avoids the permeabiliza-
tion of the injected cells. Second, a gold-conjugated sec-
ondary antibody was applied to microinjected neurons
that had been permeabilized with saponin.
In photoconversion experiments, neurons microinjected
with low concentrations of myosin Va-Cy3 antibody that
were clearly intact after fixation (noninjured or degenerat-
ing as indicated by phase contrast and fluorescence mi-
croscopy) showed dark reaction product surrounding indi-
vidual vesicle profiles in neurites (Fig. 4, A and B).
Neurons injected with higher concentrations of the myosin
Va-Cy3 antiserum that showed the large bright spots by
fluorescence microscopy also contained larger discrete ar-
eas of dark granular reaction product in cell bodies and
proximal neurites (Fig. 4 C). These areas were always as-
sociated with multiple organelle profiles, suggesting that
the antibody aggregated vesicles through its cross-linking
ability. Controls (noninjected cells subjected to irradia-
tion) showed no reaction product.
In one experiment, a microinjected cell showing only the
small spots of myosin Va-Cy3 fluorescence was fixed, per-
meabilized, and then incubated with a secondary antibody
conjugated to 6 nm colloidal gold. Thin sections from this
cell showed discrete labeling of individual structures that
resembled organelle profiles (Fig. 4 D). These results indi-
cate that the rapidly moving spots in neurites of cells mi-
croinjected with the myosin Va-Cy3 antiserum are likely
to be individual vesicles.
Figure 3. The microinjected myosin Va-Cy3 antibody partially
colocalizes with anti–SV2 labeling. (A) From a rat SCG neuron
microinjected with a low concentration of the conjugated antise-
rum. Red is the myosin Va-Cy3 antibody and green is the mono-
clonal anti–SV2 staining. Yellow indicates that many of the spots
(arrowheads) correspond. (B) From a rat cell that was injected
with a higher concentration of the myosin Va-Cy3 antibody and
then fixed and stained as in A. The large spots are yellow, indi-
cating staining for both myosin Va and SV2 in all visible spots.
Experiments done with an unconjugated myosin Va antibody
also produced large spots that stained with the SV2 monoclonal
antibody (not shown). Bars: (A) 2.5 mm; (B) 3.6 mm.Bridgman Myosin Va Dynamics 1051
Colocalization of a GFP–Myosin Va Tail Fusion 
Protein Fluorescence with Antibody Staining for 
Myosin Va and SV2
A different method of marking myosin Va–associated or-
ganelles was necessary to: (a) control for the possible ef-
fects of surface antibody binding on myosin Va function,
and (b) allow labeling of myosin Va–associated structures
in dilute-lethal neurons. There is evidence that the globular
tail portion of the myosin Va protein is responsible for its
putative interaction with organelle surfaces (Cheney et al.,
1993). Expression of a GFP–myosin Va construct contain-
ing this domain would be expected to produce a fusion
protein capable of binding to organelles. In melanocytes,
cultured cells and yeast expression of similar constructs
have been shown to target the tail truncate to the full-
length myosin V’s normal location (Bizario et al., 1998;
Wu et al., 1998; Reck-Peterson et al., 1999). At appropri-
ate expression levels, this would provide a marker for in-
dividual organelles that normally associate with native
myosin Va. To determine if a rat GFP–myosin Va tail con-
struct could act as an appropriate marker, we expressed
it (designated as GFP–myosin Va-t) in cultured SCG
neurons. We then used immunofluorescence with a myo-
Figure 4. Photoconversion of the microinjected myosin Va-Cy3–
labeled antibody produces dark reaction product spots that are
associated with organelles. (A and B) Two examples showing or-
ganelles in neurites that extended from different identified rat
neuronal cell bodies injected with low concentrations of the anti-
serum. In both cases, single vesicle profiles are surrounded by
dark reaction product (arrows). (B) A thin section from a photo-
converted rat neuronal cell body that was injected with a high
concentration of the myosin Va-Cy3 antiserum. This cell body
contained large bright fluorescent spots before photoconversion.
Membrane-bound organelles (arrowheads) surround the dark re-
action product. The light spots within the dark area probably rep-
resent vesicle profiles. (D) A thin section from a rat neuronal cell
body microinjected with a low concentration of antibody. This
cell was permeabilized and then incubated with 6 nm gold-conju-
gated anti–rabbit antibody instead of photoconversion. The small
gold particles label two irregular shaped membrane profiles (part
of the membrane surface is within the section thickness). Bars:
(A–C) 180 nm; (D) 70 nm.
sin Va antibody (Dil-2, gift of John Hammer) that was
treated so that it lacked reaction with the expressed fusion
protein to determine if it was correctly targeted in mouse
neurons. Most heterozygous cell bodies appeared bright
and fluorescence could be detected at low magnification in
all neurites emerging from the cell body. At higher magni-
fication, the fluorescence consisted mainly of bright spots
of varying size and intensity. In cell bodies, bright irregular
shaped spots were frequently seen in the perinuclear re-
gion and near the plasma membrane. Large bright spots
were also seen in proximal portions of some neurites, but
most neurites contained only small spots. Terminal vari-
cosities in older cultures (.2 d) contained many small dim
spots and an occasional bright spot of fluorescence. Nearly
complete overlap in the distribution of GFP–myosin Va-t
and myosin Va immunofluorescence label was observed in
thin neurites (Fig. 5, A and B). Similar overlap was seen in
cell bodies, growth cones, or terminal, but the increased
thickness made it more difficult to determine the precision
of the colocalization. The exception was very bright large
GFP spots (possibly vacuoles) located in a few cell bodies
that increased in size and number with time in culture.
Similar large very bright spots were seen in most nonneu-
ronal cells. The large very bright spots showed weak or no
colocalization with myosin Va antibody staining (not
shown). We assume that the very bright spots in these cell
bodies (and nonneuronal cells) represent sequestered and/or
degraded GFP–myosin Va-t fusion protein. Cells showing
such large bright spots were not used for analysis of spot
movement or cell body brightness. Dilute-lethal neurons
showed a similar distribution of the GFP–myosin Va-t.
However, no specific DIL-2 antibody staining was seen in
the cells expressing GFP–myosin Va-t, indicating that the
antibody did not recognize the expressed myosin Va tail
fusion protein (Fig. 5, C and D).
Colocalization of the GFP-myosin Va-t small spots of
fluorescence with SV2 immunofluorescence were also ob-
served in cells fixed and then stained with a monoclonal
antibody to SV2 (Fig. 5, E and F). Although we did not
quantitate the degree of colocalization, it resembled that
seen with the microinjected myosin Va-Cy3 antibody.
Dynamics of a GFP-Myosin Va-t in Cultured SCG 
Neurons from Normal Rats or Heterozygous Mice and 
Dilute-Lethal Mice
To compare the dynamics of myosin Va–associated organ-
elles in normal and dilute-lethal neurons, we used time-lapse
recording to obtain quantitative data on their movements
in neurons transfected with myosin Va-t. Unexpectedly,
expression of the GFP-myosin Va-t construct in neurons
cultured from dilute-lethal mice resulted in bright spots
with similar characteristics to those observed in neurons
from rats and heterozygous mice (Fig. 6). Small bright flu-
orescent spots were distributed along the entire length of
both dilute-lethal and control neurites. No detectable accu-
mulation of bright spots was observed in cell bodies of di-
lute-lethal neurons. Consistent with this observation, the
peak brightness of neuronal cell bodies from heterozygous
or dilute-lethal mice showed no significant difference (P .
0.2; heterozygous 5 9,982 6 3,220 iu, n 5 4, dilute-lethal 5
7,765 6 2,424 iu, n 5 5). Surprisingly, z10% of the spotsThe Journal of Cell Biology, Volume 146, 1999 1052
larly, recordings from transfected SCG neurons from rat
embryos or heterozygous mice revealed that z10% of the
fluorescent spots in neurites were undergoing movement
(Fig. 6). To determine whether small spots that remained
stationary in neurites during an entire sequence of record-
ing might represent a different population than moving
spots, we compared their peak brightness. Consistent with
this idea, the stationary spots gave a brighter mean value
(2,865 6 1,089 iu, n 5 21) than moving spots (1,065 6 426
iu, n 5 14), and the difference was significant (t test, P ,
0.001). Similar to the microinjected myosin Va-Cy3 antise-
rum, sometimes spots that were stationary at the start of
recording began to move and motile spots stopped moving
(and were therefore categorized as moving spots). Moving
spots also showed short pauses and direction reversals
characteristic of saltatory movement (Fig. 6 C). Movement
was bi-directional and was biased toward anterograde
movement. In dilute-lethal neurons, 88% of the spots ana-
lyzed for speed (21/24) moved in the anterograde direc-
tion. We also scored the direction of movement of all spots
in eight sequences. Again, the movement was predomi-
nantly in the anterograde direction (26/30 or 87%). In con-
trast, in the rat or heterozygous neurons, only 64% per-
cent of the spots selected for quantitative analysis made
anterograde movements. In five 6-min time-lapse se-
quences, the directions of all moving particles were scored.
68% (23/34) made anterograde movements. While chi-
square analysis indicated that the apparent anterograde
bias observed in neurites from rat or heterozygous mice
was not statistically significant, the anterograde bias ob-
served in dilute-lethal neurites was significant (P , 0.01).
There was no detectable difference in maximum or av-
erage rates observed in SCG neurons from rats compared
with heterozygous mice and so the results have been
pooled (Fig. 6 D). The maximum rate was significantly
greater (t test, P , 0.02) than that obtained with the mi-
croinjected myosin Va-Cy3 antibody. However, the aver-
age transport rates were the same (myosin Va-Cy3 anti-
body 5 0.18 6 0.09, n 5 40 vs. GFP-myosin Va-t 5 0.15 6
0.07 mm/s, n 5 23). Comparison of the maximum rates of
particle movements in cells derived from rats and het-
erozygous mice to those in cells from dilute-lethal mice in-
dicated that the latter were significantly faster (Fig. 6, D
and F, t test, P 5 0.01). Thus, myosin Va activity may
dampen the speed of organelle transport similar to that
observed in melanocytes (Wu et al., 1998; see also Morris
and Hollenbeck, 1995). However, the average rates were
not significantly different (0.15 6 0.07 mm/s, n 5 23 vs.
0.22 6 0.21 mm/s, n 5 21, P . 0.1), because the pauses and
direction reversal have more impact on the average rate
than the small difference in maximum rate.
Nocodazole Treatment Alters the Dynamics of Myosin 
Va–associated Organelles in Cultured SCG Neurons 
The above results indicate that motors other than myosin
Va must contribute to the movement of myosin Va–associ-
ated organelles. The high rates of movement suggest that
microtubule motors might be involved. To determine
whether microtubules were necessary for the rapid move-
ments of myosin Va–associated organelles, chronic appli-
cation of nocodazole was used to depolymerize microtu-
Figure 5. GFP-myosin Va-t fluorescence is correctly targeted in
neurons as indicated by colocalization with immunofluorescence
staining for myosin Va or SV2. The DIL-2 antibody to myosin Va
used for staining was made to amino acids 910–1106 of the myo-
sin Va heavy chain (Wu et al., 1997). This overlapped by two
amino acids with the sequence used for the GFP-myosin Va-t fu-
sion protein. To remove a cross-reacting epitope resulting from
this overlap, the antiserum was preincubated with a purified
GST-myosin Va-t fusion protein coupled to agarose beads. The
beads were pelleted by centrifugation and the supernatant used
for immunofluorescence staining. (A) GFP-myosin Va-t fluores-
cence in a neurite from a heterozygous mouse. Arrowheads indi-
cate bright spots of staining along the length of the neurite. (B)
Immunofluorescence image of the same area as in A using the
preabsorbed DIL-2 antibody. Bright spots of fluorescence (ar-
rowheads) in the neurite correspond with the bright spots seen in
A. The neurite lies along the surface of nonneuronal cells that
also show bright spots of antibody stain. (C) GFP-myosin Va-t
fluorescence in a neurite from a dilute-lethal mouse. (D) Immu-
nofluorescence image of the same area as in C using the preab-
sorbed DIL-2 antibody. The fluorescence does not colocalize, in-
dicating that the preabsorbed antibody does not cross-react with
the GFP-myosin Va-t fusion protein. The few bright spots ob-
served are nonspecific staining. (E) GFP-myosin Va-t fluores-
cence in a neurite from a heterozygous mouse. (F) Immunofluo-
rescence image of the same area as in E using a mAb to SV2. The
brightest spots in the two images show colocalization (arrow-
heads). Bar, 1.5 mm.
in any one sequence recorded from neurites of dilute-lethal
neurons were undergoing rapid movements. Since myosin
Va cannot be the motor in dilute-lethal neurons, other mo-
tor proteins must be responsible for the movement. Simi-Bridgman Myosin Va Dynamics 1053
bules. Cells were plated and then grown in the continuous
presence of the nocodazole (3.3 mg/ml) for 3–6 d (Morris
and Hollenbeck, 1995). Microtubules were completely
eliminated from the broad lamellae and short processes
produced by the treated neurons under these conditions
(Fig. 7). Despite the difference in morphology, nocoda-
zole-treated cells microinjected with myosin Va-Cy3 anti-
body showed a similar distribution of fluorescent spots to
untreated cells (Fig. 7). Fluorescent spot movements were
still apparent in time-lapse recordings, but moved at re-
Figure 6. Sequences showing
movement of GFP-myosin Va-t
in SCG neurons derived from
heterozygous (A) and dilute-
lethal (B) mice. Stationary and
moving spots (arrowheads) are
observed in axons from both
types of mice (5-s intervals are
depicted). A portion of the cell
body (arrow) is seen in A. The
moving spot in B is elongated or
a series of connected spots. (C)
Displacement over time of indi-
vidual GFP-myosin Va-t parti-
cles in SCG neurons derived
from heterozygous mice. Bidi-
rectional movements are ob-
served. (D) The maximum rate
of particle movements observed
in neurites from heterozygous
mice (n 5 23) and rats (n 5 7).
(E) Displacement over time of
individual GFP-myosin Va-t in
SCG neurons derived from di-
lute-lethal mice. Particles in di-
lute-lethal neurons tended to
make larger jumps between time
points. (F) The maximum rate of
particle movements observed in
neurites from dilute-lethal mice.
The maximum rates achieved for
some particles are greater than
those observed in neurons
from heterozygous mice. Bar,
5.8  mm.The Journal of Cell Biology, Volume 146, 1999 1054
duced rates (Fig. 8, A and E). Fluorescent spots (particles)
paused and reversed direction more frequently than in un-
treated cells (compare Figs. 8 A and 2 B). A sizable and
significant decrease (t test, P , 0.001) occurred in maxi-
mum rate (0.1 6 0.05 mm/s, n 5 12) in the absence of mi-
crotubules (compare Figs. 8 E and 2 C).
Similarly, SCG neurons from embryonic rats or P0 het-
erozygous mouse pups cultured for 3 d in medium contain-
ing nocodazole and then transfected with GFP-myosin Va-t
showed fluorescent spots distributed throughout the entire
length of their short processes. Time-lapse recordings re-
vealed that small spots in the short neurite-like processes
moved at significantly reduced average and maximum
rates (t test, P , 0.001) compared with untreated cells
(Fig. 8, B and F). After recordings, cultures were fixed and
immunofluorescently stained for actin and microtubules.
Identical to cells used for antibody microinjection, short
microtubules segments were sometimes observed in the
perinuclear region, but most cells lacked microtubules in
the broad lamellae and short neurite-like processes used
for time-lapse recordings.
In cells from dilute-lethal mice that were grown under a
modified nocodazole treatment protocol, GFP-myosin Va-t
fluorescent spots were absent from the distal portions of
processes, but were present at the base and in more proxi-
mal portions. Time-lapse recordings indicated that the
small fluorescent spots within the processes appeared to
make only short back and forth movements. Quantitative
analysis indicated that the net displacement of spots dur-
ing the recordings were extremely small (Fig. 8 C). The
calculated rates of movement (maximum 5 0.04 6 0.01
mm/s, average 5 0.005 6 0.004 mm/s, n 5 19) were signifi-
cantly less (t test, P , 0.001) than the maximum and aver-
age rates of movements seen in heterozygous cells treated
with nocodazole. This suggests that the small back and
forth movements that were observed were not directed,
but are likely to be Brownian-like. The very small rate of
displacement was the same as the slow movement of large
bright spots observed in cells microinjected with high con-
centrations of myosin Va-Cy3 antibody. This movement
may result from other non–myosin Va-dependent mecha-
nisms. Similar slow movements have been reported in di-
lute-lethal melanocytes (Wu et al., 1998).
Dilute-lethal cultures used for recordings were fixed and
labeled with rhodamine phalloidin and a monoclonal anti-
body to tubulin to reveal the distribution of F-actin and
microtubules. Similar to cells plated directly in nocoda-
zole, microtubules were sometimes present in the perinu-
clear region, but were absent from the lamellae and most
short processes that extended from the cell body. Unlike
cells plated directly in nocodazole, very small, discontinu-
ous microtubule segments were occasionally observed in
the shortened processes, suggesting that some microtubule
segments formed in processes before nocodazole exposure
were stabilized. However, in the processes of nocodazole-
treated cells from dilute-lethal mice, we never observed
movements of GFP-myosin Va-t that were clearly di-
rected.
Latrunculin Treatment Does Not Significantly Effect 
Myosin Va–associated Organelle Movement
To determine whether actin-based motors might contrib-
ute to the rapid movements of myosin Va–associated or-
ganelles, SCG neurons from heterozygous mice were
grown for 3 d in medium containing latrunculin A. Neu-
rons had altered morphology (Marsh and Letourneau,
1984), and lacked detectable actin filaments when stained
with rhodamine phalloidin (not shown). Neurons express-
ing GFP-myosin Va-t showed fluorescent spots distributed
along the entire length of their processes. Time-lapse re-
cordings revealed the rapid movement of small GFP-myo-
sin Va-t spots in neurites (Fig. 8 D). The maximum rates of
movement were significantly greater (t test, P , 0.001)
Figure 7. Rat SCG neurons
grown for 3 d in nocodazole (3.3
mg/ml),  and then microinjected
with anti–myosin Va-Cy3 anti-
body lack microtubules in cell
processes. The distribution of ac-
tin (A and D), microinjected
myosin Va-Cy3 antibody (B and
E), and microtubules (C and F)
are shown in two cells (B) used
for recording movements of my-
osin Va-Cy3 antibody spots. The
boxed regions in A indicate the
areas used for recordings. Al-
though some residual microtu-
bule segments can be observed
in the perinuclear region of one
noninjected cell (C), they are ab-
sent from cell processes that ex-
tend peripherally in the injected
cells (C and F). D and F are high
magnifications of a portion of
the cell indicated by the boxed
region (right side) in A. Bars:
(A–C) 21.5 mm; (B–F) 5 mm.Bridgman Myosin Va Dynamics 1055
Figure 8. Quantitative analysis
of myosin Va (antibody or GFP-
myosin Va-t) movements in neu-
rites treated with nocodazole
and latrunculin A. (A) The dis-
placement of individual myosin
Va-Cy3 antibody spots (parti-
cles) along neurites in rat cells
grown for 3 d in nocodazole. The
displacement between time
points is much less than in un-
treated cells (see Fig. 2). Pauses
and direction reversals appear
more numerous than in un-
treated cells. Positive values indi-
cate movement away from the
cell body. (B) The displacement
of individual GFP-myosin Va-t
spots along neurites in SCG neu-
rons from heterozygous mice
grown for 3 d in nocodazole.
Movement is saltatory; particles
pause and temporarily reverse
direction, but progress generally
in a single direction. (C) The dis-
placement of individual GFP-
myosin Va-t spots in neurons
from  dilute-lethal mice grown in
nocodazole. The particles oscil-
late around the zero point. (D)
The displacement of individual
GFP-myosin Va-t spots along
neurites in SCG neurons from
heterozygous mice grown for 3 d
in latrunculin. Movement is
greater between time points, is
bi-directional, and shows fewer
pauses and direction reversals
than in nocodazole. (E) The
maximum rate of myosin Va-Cy3
antibody spot movement in cells
grown for 3 d in nocodazole. The
mean maximum rate of move-
ment is significantly slower (t
test; P , 0.001) than in untreated
cells (see Fig. 2). (F) The maxi-
mum rates of GFP-myosin Va-t
spot movement in SCG neurons
from heterozygous mice grown
for 3 d in nocodazole. The mean
maximum rate shows a large de-
crease compared with maximum
rates of movement in untreated
or latrunculin-treated neurons.
(G) The maximum rates of GFP-
myosin Va-t spot movement in
SCG neurons grown for 3 d in la-
trunculin. The mean of the maxi-
mum rates of GFP-myosin Va-t
movements are significantly
greater (t test; P , 0.001) in la-
trunculin compared with no-
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than those observed in nocodazole-treated cells (Fig. 8 G).
Although the maximum rate of spot movement was
slightly less than the maximum rate observed in untreated
cells, the difference was not significant (t test, P 5 0.1).
This indicates that actin-based motors are not necessary
for rapid movements in axons
Comparison of SV2 and Synaptic Vesicle Distribution 
in Neurons from Heterozygous and Dilute-Lethal Mice
If the capture model for melanosome accumulation in pe-
ripheral dendrites of melanocytes (Wu et al., 1998) holds
for myosin Va–associated organelle distribution in neu-
rons from dilute-lethal mice, then one would predict: (a) a
concentration of myosin Va–associated organelles within
cell bodies of neurons, and (b) a depletion of the same or-
ganelles from their peripheral target.
We had not observed accumulation of GFP-myosin Va-t
label in cell bodies of dilute-lethal neurons. However, be-
cause the observations were done at relatively short times
(,20 h) after the beginning of the GFP-myosin Va-t ex-
pression, it is possible that accumulation would only be de-
tected with increased time.
To address this possibility, the distributions of anti–SV2
label in 3-d-old dissociated cultures of SCG neurons from
heterozygous and dilute-lethal mice were compared. Be-
cause SV2 shows a high degree of colocalization with
bright spots of myosin Va, it should provide a good inde-
pendent marker of myosin Va–associated organelles. The
peak brightness of SV2 label in cell bodies of dilute-lethal
neurons was slightly greater than those from heterozygous
controls (dilute-lethal 5 778 6 45 iu, n 5 4 vs. heterozy-
gous 5 639 6 48 iu, n 5 8), but the difference was not sig-
nificant (P . 0.1). This indicates that SV2 does not accu-
mulate in cell bodies of dilute-lethal neurons, consistent
with the observation that transport of myosin Va–associ-
ated organelles is biased towards anterograde movement.
The brightness of SV2 label was also compared in re-
gions that showed the brightest SV2 label in neurites: vari-
cosities, branch points, and axon terminations. The com-
parison was done under two different culture conditions:
in 3-d-old low-density dissociated cell culture (cells were
not contacting each other), and in explants grown for 5 d.
In the low-density dissociated cultures, varicosities, branch
points, and terminations of dilute-lethal neurons showed a
significant increase (P , 0.001) in peak brightness (dilute-
lethal 5 1,068 6 220 iu, n 5 11 vs. heterozygous 5 678 6
89 iu, n 5 14), indicating that SV2 does accumulate pe-
ripherally within these regions.
The regions showing accumulation of SV2 label also co-
labeled with a monoclonal antibody to tyrosinated tubulin
(Fig. 9). Since tyrosinated tubulin is associated with dy-
namic plus ends of microtubules, it suggests that these re-
gions contain dynamic microtubule ends. The degree of
colocalization was 100%. In other words, the presence of
bright SV2 label could predict the occurrence of bright ty-
rosinated tubulin label and vice versa. To insure that the
low density of cells were not affecting the accumulation of
SV2, the peak brightness of SV2 label was also compared
in neurites of 5-d-old explant cultures. Under these condi-
Figure 9. SV2 accumulates in
axon terminations of heterozy-
gous and dilute-lethal neurons
that are rich in tyrosinated tubu-
lin. (A) The actin distribution is
depicted in the terminal portion
of an axon from a SCG neuron
grown from a heterozygous
mouse. (B) Wide areas of the
axon (arrowheads in A) show in-
creased staining for SV2 (arrow-
heads). (C) The areas of SV2 ac-
cumulation also correspond to
the brightest areas (arrow-
heads) of tyrosinated tubulin
staining. (D) The actin distribu-
tion is shown for a terminal por-
tion of a SCG neurite grown
from a dilute-lethal mouse. (E)
Wide areas of axons (arrow-
heads in D) show increased
bright staining for SV2 (arrow-
heads). (F) The areas of SV2 ac-
cumulation seen in E correspond
to bright areas of tyrosinated
tubulin staining (arrowheads).
Bars, 6 mm.Bridgman Myosin Va Dynamics 1057
tions, neurites grow out radially from explants and do not
form synapses (outside the body of the explant). Dilute-
lethal neurons showed significant increases (P , 0.001) in
the peak brightness of staining in varicosities, (dilute-lethal 5
6,378 6 1,289 iu, n 5 14 vs. heterozygous 5 4,155 6 400 iu,
n 5 12).
Second, the distribution of anti–SV2 antibody label was
compared on cryostat sections taken from the cerebellum
of either heterozygous or dilute-lethal mice. We compared
the peak intensity of label in bright puncta in three regions
of individual sections: the granule cell layer, the region
surrounding Purkinje cell bodies, and the outer portion of
the molecular layer. The granule cell layer of the heterozy-
gous sample had a significantly (P 5 0.05) brighter stain-
ing than the dilute-lethal sample (heterozygous 5 2,905 6
423, n 5 13 vs. dilute-lethal 5 2,538 6 367, n 5 10). In
contrast, the portion of the molecular layer immediately
adjacent to Purkinje cells had significantly (P , 0.001)
brighter staining in the dilute-lethal sample (dilute-lethal 5
3,342 6 197, n 5 10 vs. heterozygous 5 2,171 6 367, n 5
8). Similarly, the outer portion of the molecular layer had
significantly (P , 0.001) brighter staining in the dilute-
lethal sample (dilute-lethal 5 2,820 6 536, n 5 42 vs. het-
erozygous 5 1,974 6 381, n 5 30). This suggests that SV2
accumulates to abnormal levels in dilute-lethal granule cell
axons and presynaptic terminals, similar to the peripheral
accumulation in cultured SCG neurons.
Third, the terminal area and density of synaptic vesicles
in synapses from heterozygous and dilute-lethal mouse lit-
termates were compared in two different presynaptic ter-
minals. The presynaptic terminals of P12 Purkinje cells did
not show significant differences (P . 0.5) in terminal
cross-sectional area (heterozygous area 5 1.1 6 0.24 mm2,
n 5 6, dilute-lethal area 5 1.3 6 0.67 mm2, n 5 5) or synap-
tic vesicle density (heterozygous 5 259 6 89 vesicles/mm2,
dilute-lethal 5 310 6 114 vesicles/mm2). In contrast, the
presynaptic terminals of granule cells appeared to have a
much larger average terminal cross-sectional area in di-
lute-lethal mice at all ages that were inspected (P10, P12,
P14, P15, P18) (Fig. 10). At P18, the difference was more
than fivefold (heterozygous area 5 0.76 6 0.36 mm2, n 5
21 vs. dilute-lethal area 5 4.36 6 3.6 mm2, n 5 12, differ-
ence was significant, P , 0.001). Synaptic vesicle density
was somewhat lower in these enlarged dilute-lethal termi-
nals (P18 heterozygous 5 25 6 8 vesicle/mm2, vs. P18 di-
lute-lethal 5 18 6 12 vesicles/mm2, P 5 0.05). At P10 the
difference in presynaptic terminal area was not as great
(heterozygous area 5 0.41 6 0.26 mm2, n 5 37 vs. dilute-
lethal area 5 0.96 6 0.61 mm2, n 5 22), but the difference
was still significant (P , 0.001). P10 is before the onset of
seizures in dilute-lethal mice (our unpublished observa-
tions), indicating that the increase in presynaptic terminal
area is not a secondary effect of the seizures. The greater
area indicates that the presynaptic terminal volume of
granule cells will be increased in dilute-lethal mice. Be-
cause of the increased volume, the total number of synap-
tic vesicles in these terminals will be greater.
Finally, the amounts of SV2 label in granule cell presyn-
aptic terminals of dilute-lethal and heterozygous mice were
compared using immunoelectron microscopy. Presynaptic
terminals of labeled P15 dilute-lethal granule cells had a
significantly greater number of synaptic vesicles per termi-
nal profile compared with heterozygous littermates as a
result of the increased terminal area (Table I). However,
the number of anti–SV2-labeled synaptic vesicles (and
gold particles) per terminal profile were the same (Fig. 10
and Table II). In contrast, dilute-lethal presynaptic termi-
nals had slightly more than twice as many large vesicles
(.80-nm diameter) per terminal profile that were labeled
with the anti–SV2 antibody. In addition, dilute-lethal mice
had more anti–SV2 label of large vesicles in parallel fibers
away from synaptic sites. This suggests that the increased
SV2 staining in the molecular layer of the dilute-lethal cer-
ebellum observed by fluorescence microscopy is at least
partially a result of the increased accumulation of large
SV2 positive vesicles in or near presynaptic terminals.
Discussion
Microinjected Myosin Va-Cy3 Antiserum or Expression 
of GFP-Myosin Va-t Labels Organelles
Two different observations support the conclusion that the
microinjected myosin Va-Cy3 antibody labels organelles
Figure 10. (A) Cross-sectional synaptic profiles of parallel fiber
boutons and Purkinje cell dendritic spines from the molecular
layer of a P18 heterozygous mouse. Parallel fiber boutons are
small and relatively uniform in size. Each bouton contacts a sin-
gle spine. Purkinje cell spines contain smooth endoplasmic retic-
ulum (arrowheads). (B) Cross-sectional profile of a single large
parallel fiber bouton making contact with three (1, 2, and 3)
Purkinje cell spines from the molecular layer of a P18 dilute-
lethal mouse. Spines lack smooth endoplasmic reticulum. (C)
The distribution of SV2 antibody label (12 nm colloidal gold) in a
parallel fiber bouton from a heterozygous mouse. Many of the
synaptic vesicles (arrowheads) are labeled. Some larger vesicles
(arrows) also show label in this oblique section. (D) The distribu-
tion of SV2 antibody label in a parallel fiber bouton from a di-
lute-lethal mouse. Synaptic vesicles (arrowheads) are labeled.
(Inset) From another synaptic terminal showing SV2 antibody la-
bel on several larger vesicles (arrows). (E) A nonterminal region
of a parallel fiber also shows SV2 antibody labeling of large vesi-
cles in the molecular layer of a dilute-lethal mouse. Bars: (A and
B) 470 nm; (C–E) 315 nm.The Journal of Cell Biology, Volume 146, 1999 1058
by binding to their surfaces. First, small spots partially
colocalized, and very bright spots showed 100% colocal-
ization, with antibody staining for SV2, an integral mem-
brane protein that is a common marker for synaptic vesi-
cles or their precursors (Feany et al., 1992). Second,
ultrastructural observations on photoconverted cells that
showed small fluorescent spots represented individual or-
ganelles surrounded by DAB reaction product. Large flu-
orescent spots represented antibody-induced organelle
aggregates. In nonphotoconverted cells labeled with col-
loidal gold particles, individual organelle-like structures
were associated with gold label on their surfaces. Thus, the
accumulated evidence is most compatible with the exter-
nal binding and concentration-dependent aggregation of
vesicular structures by the microinjected myosin Va-Cy3–
conjugated antibodies. The presence of individual labeled
organelles within neurites suggests that many of the mov-
ing spots observed in time-lapse recordings represent indi-
vidual vesicles.
The size of the individual labeled organelles found
within neurites was highly variable, but in most cases they
were much larger (.80 nm) than synaptic vesicles. It has
been reported that some synaptic vesicle proteins are ax-
onally transported in pleomorphic vesicles (Nakata et al.,
1998). This observation, in combination with the data indi-
cating an almost 50% colocalization with the synaptic vesi-
cle protein SV2, suggests that many of the myosin Va–
associated vesicles that move in axons may represent
synaptic vesicle precursors. It has also been reported that
SV2 is axonally transported in separate organelle com-
partments from other synaptic vesicle components, includ-
ing synaptophysin (Okada et al., 1995; Yonekawa et al.,
1998). The difference in myosin Va–associated organelle
colocalization with SV2 and synaptophysin in neurites is
consistent with that observation.
Movement of Myosin Va–associated Organelles in 
Normal and Dilute-Lethal Axons Occurs at Similar 
Rates and Is Bidirectional, but in Dilute-Lethal Axons 
It Is Biased Toward Anterograde Movement
The maximum and average rates of movement of both
myosin Va-Cy3 antibody and GFP-myosin Va-t–labeled
organelles are similar, suggesting that they act as good
markers for myosin Va organelle dynamics. The general
characteristics of the movement were also the same. Both
were bi-directional and saltatory. Movement of GFP-myo-
sin Va-t–labeled organelles in neurons from dilute-lethal
animals was also similar to that observed in normal cells,
although a bias towards anterograde movement was ob-
served. Furthermore, in untreated cells from both normal
and dilute-lethal mice, the maximum rates of movement
exceed that observed with purified myosin Va–associated
vesicles (Evans et al., 1998). Thus, motors other than myo-
sin Va must be responsible for the rapid movements ob-
served. Likely candidates are microtubule-based motors.
Consistent with that possibility, the maximum rates of
movement are the same as that observed for organelles
known to be transported by kinesins (Nakata el al., 1998;
Yonokawa et al., 1998).
Rapid Movements of Myosin Va–associated Organelles 
Are Microtubule Dependent
The maximum rate of myosin Va–associated organelle
movement is significantly decreased when normal cells are
grown in the presence of nocodazole to prevent microtu-
bule polymerization, indicating that microtubules proba-
bly represent the transport tracks responsible for the most
rapid movements. Treatment with nocodazole to effec-
tively eliminate microtubules does not stop directed move-
ment. Presumably, F-actin acts as transport tracks under
these conditions and the organelles are able to move at re-
duced rates using myosin motors.
In contrast to normal cells, movements of GFP-myosin
Va-t are absent in dilute-lethal neurons grown under con-
ditions to eliminate most microtubules. This indicates that
myosin Va activity is required for movement of these or-
ganelles when microtubules are disrupted. This is the first
evidence available to directly support myosin Va–medi-
ated organelle movements in intact neurons. It is consis-
tent with recent observations on melanocytes where myo-
sin Va appears to mediate movement of melanosomes in
the absence of microtubules (Wu et al., 1998). Further-
more, it supports the conclusion that individual organelles
contain both actin- and microtubule-based motors. While
the results only require that both types of motors be
present on the same organelle, they are also consistent
with the possibility that a single motor complex with dual
functions may exist.
Can the Capture Model Explain the Abnormalities 
Observed in Dilute-Lethal Neurons?
Neurons from dilute-lethal mice do not show abnormal ac-
cumulations of myosin Va–associated organelles in cell
bodies similar to the perinuclear accumulation of melano-
somes in melanocytes (Provance et al., 1996; Wei et al.,
1997; Wu et al., 1997). The lack of accumulation is likely to
be a result of the anterograde bias associated with trans-
port of myosin Va–associated organelles in dilute-lethal
neurons. The bias could be a result of a change in the bal-
ance of retrograde and anterograde microtubule-based
motors associated with these organelles. Alternatively,
there may be a change in the efficiency of access to micro-
tubule tracks in peripheral regions that contain lower mi-
crotubule densities or increased numbers of microtubule
Table I. Comparison of Synaptic Vesicle Number and SV2 Immunogold Label in Normal and Dilute-Lethal Parallel Fiber Boutons
Genotype
No. of synaptic
vesicles per
terminal profile
No. of synaptic
vesicles labeled
(SV2) per terminal
Percentage synaptic
vesicles labeled
per terminal
No. of large
vesicles labeled
(SV2) per terminal
Total No. of vesicle-
associated gold
particles per terminal n
Heterozygous 46 6 20* 17 6 10 37% 0.6 6 0.9‡ 31 6 19 21
Dilute-lethal 74 6 29* 15 6 10 20% 1.5 6 1.2‡ 29 6 20 17
*Significantly different, t test, P 5 0.001. 
‡Significantly different, t test, P , 0.02.Bridgman Myosin Va Dynamics 1059
ends. In support of the latter possibility, dilute-lethal neu-
rons showed increased accumulations of SV2 label in vari-
cosities, axon branches, and axon terminations. These re-
gions also show staining for tyrosinated tubulin and are
near regions that stain for F-actin. Tyrosinated tubulin is
associated with portions of microtubules that contain new
polymer or, in other words, are close to dynamic plus ends
(Kreis, 1987; Schulze et al., 1987). This suggests that myo-
sin Va–associated organelles may become stranded in re-
gions of dilute-lethal neurons that have a high concentra-
tion of dynamic microtubule plus ends. If this is the case,
then it suggests that myosin Va motor activity may facili-
tate the ability of organelles that have traveled off the
ends of microtubules, or are released as a result of depoly-
merization, to return to these tracks for transport. This is
consistent with the reduced percentage of myosin Va–
associated organelles undergoing retrograde transport in
axons of dilute-lethal neurons. Myosin Va may also medi-
ate entry of organelles into the nearby actin-rich regions
for short range transport or tethering. The peripheral ac-
cumulation of myosin Va–associated organelles in dilute-
lethal neurons is the opposite of that observed in melano-
cytes. However, the apparent incompatibility with the
capture model presented for melanocytes (Wu et al., 1998)
may be primarily a result of differences in the net balance
of anterograde and retrograde transport rather than an in-
compatibility with a myosin Va-dependent tethering.
Dendritic spines of Purkinje cells from P21 mice (a
strain obtained from Jackson ImmunoResearch Laborato-
ries, Inc.) have been reported to lack smooth endoplasmic
reticulum (Takagashi et al., 1996). We have observed a
similar defect in Purkinje cells from dilute-lethal (dl-20J/dl-
20J) pups (Strobel et al., 1990) at all ages studied (P10–
P21). It is not clear if this abnormality fits with a tethering
role because the mechanism of spine formation remains
controversial (Ziv and Smith, 1996; Fiala et al., 1998).
Dilute-Lethal Mice Have Alterations in a Subset of 
Presynaptic Terminals
If myosin Va activity is necessary only for local movement
or processing of certain organelles in regions devoid of mi-
crotubules, then the abnormalities observed in dilute-lethal
granule cell presynaptic terminals fit with this model. The
increased numbers of large SV2-positive vesicles and syn-
aptic vesicles may result from the absence of local trans-
port in dilute-lethal axon terminals. Transport of synaptic
vesicle to fusion/release sites (active zones) may be defec-
tive or loading of vesicles destined for microtubule-based
retrograde transport may be abnormal. Either defect
could lead to accumulations of vesicles in terminals. How-
ever, presynaptic terminals of Purkinje cells did not show
any noticeable defects in structure, area, or synaptic vesi-
cle density at P12.
It is unclear why some terminals appear normal and
while others are affected. It is especially surprising that
Purkinje cell presynaptic terminals do not show defects,
since their dendritic spines clearly do (Takagishi et al.,
1996; Fig. 10). However, one difference between Purkinje
cell presynaptic terminals and those of granule cells is the
type of neurotransmitter produced and released. Purkinje
cells produce an inhibitory neurotransmitter, while gran-
ule cells produce an excitatory neurotransmitter. Possibly
there are neuron-specific mechanisms of transport within
terminals for different types of synapses. Alternatively,
detection of presynaptic structural changes may be activity
dependent. Depending on the upstream abnormalities, the
output activity (and hence synaptic vesicle turnover) from
Purkinje cells may be reduced.
I thank Grady Phillips for expert technical assistance and Drs. John Coo-
per and John Hammer for comments on the manuscript. Dr. John Ham-
mer generously donated the DIL-2 antibody. 
This work was supported by National Institutes of Health grant
NS35162 to P.C. Bridgman.
Submitted: 8 April 1999
Revised: 4 August 1999
Accepted: 6 August 1999
References
Bizario, J.C.S., L.C. Rosa, A.A.C. Nascimento, R.E. Larson, and E.M. Esprea-
fico. 1998. Melanosome distribution is affected by expression of chicken my-
osin-Va constructs in wild type and dilute viral melanoma cells. Mol. Biol.
Cell. 9:20a. (Abstr.)
Cheney, R.E., M.K. O’Shea, J.E. Heuser, M.V. Coelho, J.S. Wolenski, E.M.
Espreafico, P. Forscher, R.E. Larson, and M.S. Mooseker. 1993. Brain myo-
sin-V is a two-headed unconventional myosin with motor activity. Cell. 75:
13–23.
Dailey, M.E., and P.C. Bridgman. 1993. Vacuole dynamics in growth cones: cor-
related EM and video observations. J. Neurosci. 13:3375–3393.
Espreafico, E.M., R.E. Cheney, M. Matteoli, A.A. Nascimento, P.V. De Ca-
milli, R.E. Larson, and M.S. Mooseker. 1992. Primary structure and localiza-
tion of chicken brain myosin-V (p190), an unconventional myosin with cal-
modulin light chains. J. Cell Biol. 119:1541–1557.
Evans, L.L., and P.C. Bridgman. 1995. Particles move along actin filament bun-
dles in nerve growth cones. Proc. Natl. Acad. Sci. USA. 92:10954–10958.
Evans, L.L., J. Hammer, and P.C. Bridgman. 1997. Subcellular localization of
myosin V in nerve growth cones and outgrowth from dilute-lethal neurons. J.
Cell Sci. 110:439–449.
Evans, L.L., A.J. Lee, P.C. Bridgman, and M.S. Mooseker. 1998. Vesicle-associ-
ated brain myosin-V can be activated to catalyze actin-based transport. J.
Cell Sci. 111:2055–2066.
Feany, M.B., S. Lee, R.H. Edwards, and K.M. Buckely. 1992. The synaptic vesi-
cle protein SV2 is a novel type of transmembrane transporter. Cell. 70:861–
867.
Fiala, J.C., M. Feinberg, V. Popov, and K.M. Harris. 1998. Synaptogenesis via
dendritic filopodia in developing hippocampal area CA1. J. Neurosci. 18:
8900–8911.
Harris, K.M., and J.K. Stevens. 1989. Dendritic spines of CA1 pyramidal cells in
the rat hippocampus: serial electron microscopy with reference to their bio-
physical characteristics. J. Neurosci. 9:2982–2997.
Hirokawa, N. 1993. Axonal transport and the cytoskeleton. Curr. Opin. Neuro-
biol. 3:724–731.
Huang, J.-D., S.T. Brady, B.W. Richards, D. Stenolen, J.H. Resau, N.G. Cope-
land, and N.A. Jenkins. 1999. Direct interaction of microtubule- and actin-
based transport motors. Nature. 397:267–270.
Kacza, J., W. Hartig, and J. Seeger. 1997. Oxygen-enriched photoconversion of
fluorescent dyes by means of a closed conversion chamber. J. Neurosci.
Methods. 71:225–232.
Kreis, T. 1987. Microtubules containing detyrosinated tubulin are less dynamic.
EMBO (Eur. Mol. Biol. Organ.) J. 6:2597–2606.
Kuznetsov, S.A., G.M. Langford, and D.G. Weiss. 1992. Actin-dependent or-
ganelle movement in squid axoplasm. Nature. 356:722–725.
Langford, G.M. 1995. Actin- and microtubule-dependent organelle motors: in-
terrelationship between the two motility systems. Curr. Opin. Cell Biol.
7:82–88.
Lewis, A.K., and P.C. Bridgman. 1996. Mammalian myosin 1 a is concentrated
near the plasma membrane in nerve growth cones. Cell Motil. Cytoskelet. 33:
130–150.
Lubke, J. 1993. Photoconversion of diaminobenzidine with different fluores-
cent neuronal markers into a light and electron microscopic dense reaction
product. Microsc. Res. Tech. 24:2–14.
Marsh, L., and P.C. Letourneau. 1984. Growth of neurites without filopodial or
lamellipodial activity in the presence of cytochalasin B. J. Cell Biol. 99:2041–
2047.
Mercer, J.A., P.K. Seperack, M.C. Strobel, N.G. Copeland, and N.A. Jenkins.
1991. Novel myosin heavy chain encoded by murine dilute coat colour locus.
Nature. 349:709–713.
Morris, R.L., and P.J. Hollenbeck. 1995. Axonal transport of mitochondria
along microtubules and F-actin in living vertebrate neurons. J. Cell Biol. 131:The Journal of Cell Biology, Volume 146, 1999 1060
1315–1326.
Mrini, A., H. Moukhles, H. Jacomy, O. Bosler, and G. Doucet. 1995. Efficient
immunodetection of various protein antigens in glutaraldehyde-fixed brain
tissue. J. Histochem. Cytochem. 43:1285–1291.
Nakata, T., S. Terada, and N. Hirokawa. 1998. Visualization of the dynamics of
synaptic vesicle and plasma membrane proteins in living axons. J. Cell Biol.
140:659–674.
Nascimento, A.A.C., R.G. Amaral, R.E. Bizario, R.E. Larson, and E.M. Espre-
afico. 1997. Subcellular localization of myosin-V in the B16 melanoma cells,
a wild–type cell line for the dilute gene. Mol. Biol. Cell. 8:1971–1988.
Okada, Y., H. Yamazaki, Y. Sekine-Aizawa, and N. Hirokawa. 1995. The neu-
ron-specific kinesin superfamily protein KIF1A is a unique monomeric mo-
tor for anterograde axonal transport of synaptic vesicle precursors. Cell. 81:
769–780.
Prekaris, R., and D.M. Terrian. 1997. Brain myosin V is a synaptic vesicle–asso-
ciated motor protein: evidence for a Ca21-dependent interaction with the
synaptobrevin–synaptophysin complex. J. Cell Biol. 137:1589–1601.
Provance, D., M. Wei, V. Ipe, and J. Mercer. 1996. Cultured melanocytes from
dilute mutant mice exhibit dendritic morphology and altered melanosome
distribution. Proc. Natl. Acad. Sci. USA. 93:14554–14558.
Reck-Peterson, S.L., P.J. Novick, and M.S. Mooseker. 1999. The tail of a yeast
class V myosin, myo2p, functions as a localization domain. Mol. Biol. Cell.
10:1001–1017.
Rogers, S.L., and V.I. Gelfand. 1998. Myosin cooperates with microtubule mo-
tors during organelle transport in melanophores. Curr. Biol. 8:161–164.
Schulze, E., D.J. Asai, J.C. Bulinski, and M. Kirschner. 1987. Post-translational
modification and microtubule stability. J. Cell Biol. 105:2167–2177.
Spector, I., N.R. Shochet, D. Balsberger, and Y. Kashman. 1989. Latrunculins-
novel marine macrolides that disrupt microfilament organization and affect
cell growth: I. Comparison with cytochalasin. Cell Motil. Cytoskelet. 13:127–144.
Strobel, M.C., P.K. Seperack, N.G. Copeland, and N.A. Jenkins. 1990. Molecu-
lar analysis of two mouse dilute locus deletion mutations: spontaneous dilute
lethal 20J and radiation-induced dilute prenatal lethal Aa2 alleles. Mol. Cell
Biol. 10:501–509.
Tabb, J.S., B.J. Molyneaux, D.L. Cohen, S.A. Kuznetsov, and G.M. Langford.
1998. Transport of ER vesicles on actin filaments in neurons by myosin V. J.
Cell Sci. 111:3221–3234.
Takagishi, Y., S.-i. Oda, S. Hayasaka, K. Dekker-Ohno, T. Shikata, M. Inouye,
and H. Yamamura. 1996. The dilute-lethal (dl) gene attacks a Ca21 store in
the dendritic spine of Purkinje cells in mice. Neurosci. Lett. 215:169–172.
Wei, Q., X. Wu, and J.A. Hammer III. 1997. The predominant defect in dilute
melanocytes is in melanosome distribution and not cell shape, supporting a
role for myosin V in melanosome transport. J. Muscle Res. Cell Motil. 18:
517–527.
Wolenski, J.S., R.E. Cheney, M.S. Mooseker, and P. Forscher. 1995. In vitro
motility of immunoadsorbed brain myosin V using limulus acrosomal pro-
cess and optical tweezer-based assay. J. Cell Sci. 108:1489–1496.
Wu, X., B. Bowers, Q. Wei, B. Kocher, and J.A. Hammer III. 1997. Myosin V
associates with melanosomes in mouse melanocytes: evidence that myosin V
is an organelle motor. J. Cell Sci. 110:847–859.
Wu, X., B. Bowers, K. Rao, Q. Wei, and J.A. Hammer III. 1998. Visualization
of melanosome dynamics within wild-type and dilute melanocytes suggests a
paradigm for myosin V function in vivo. J. Cell Biol. 143:1899–1918.
Yonekawa, Y., A. Harada, Y. Okada, T. Furrakoshi, Y. Kanai, Y. Takei, S.
Terada, T. Noda, and N. Hirokawa. 1998. Defect in synaptic vesicle precur-
sor transport and neuronal cell death in KIF1A motor protein-deficient
mice.  J. Cell Biol. 141:431–441.
Ziv, N.E., and S.J. Smith. 1996. Evidence for a role of dendritic filopodia in syn-
aptogenesis and spine formation. Neuron. 17:91–102.